Idexx Laboratories
IDEXX Laboratories, Inc., a leader in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 1983, the company has established itself as a key player in veterinary diagnostics, water testing, and livestock and poultry health. With a strong presence in North America, Europe, and Asia, IDEXX is renowned for its innovative products and services that enhance animal health and improve food safety.
The company’s core offerings include diagnostic tests, software solutions, and laboratory services, all designed to provide accurate and timely results. IDEXX's commitment to research and development has led to numerous advancements, solidifying its market position as a trusted partner for veterinarians and agricultural professionals. Notable achievements include pioneering technologies that have transformed veterinary practices and contributed to global health initiatives.
-15 vs industry average
Idexx Laboratories’s score of 23 is lower than 37% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Idexx Laboratories?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Idexx Laboratories's reported carbon emissions
Idexx Laboratories, a US-based Pharmaceutical Preparation Manufacturing company, has set ambitious targets to reduce its environmental impact. For 2024, the company reported Scope 1 emissions of approximately 18.5 million kg CO2e and Scope 2 emissions of about 20.2 million kg CO2e. This continues a trend of increasing emissions from 2023, where Scope 1 was around 16.5 million kg CO2e and Scope 2 was approximately 18.6 million kg CO2e. In 2022, Scope 1 emissions were approximately 16.1 million kg CO2e and Scope 2 emissions were about 18 million kg CO2e.
Idexx Laboratories is committed to reducing its Scope 1 and 2 greenhouse gas (
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Idexx Laboratories’s Climate Goals (2030 & 2050)
2 goals2030
37.8% reduction in Scope 1
we established greenhouse gas (GHG) emissions goals, including reducing our Scope 1 and 2 GHG emissions by 37.8% by 2030,
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project